Mutations in the chromatin-remodeling protein ATRX cause alpha thalassaemia and mental retardation, but the severity of the disorder is independent of the specific mutation. In this issue of Cell, Law et al. (2010) demonstrate that ATRX alters gene expression by binding to G-rich tandem repeats, and the degree of transcriptional silencing caused by ATRX mutations correlates with the number of repeats.
The alpha thalassaemia/mental retardation syndrome X-linked gene, or ATRX, encodes a large helicase protein involved in maintaining chromatin structure. Patients with mutations in the ATRX gene typically exhibit severe mental retardation, development defects, and a blood disease called alpha thalassaemia, characterized by a deficiency in the alpha globin protein.
Approximately 113 unique mutations in the ATRX gene have been identified from >180 families, but exactly how these mutations alter gene expression is not well understood. Now Law et al. (2010) make significant progress toward answering this question by identifying where ATRX binds in both the human and mouse genomes. In addition, they provide an explanation for why patients with identical mutations in the ATRX gene display a broad variation in phenotypes.
The ATRX gene encodes at least two alternatively spliced transcripts that give rise to slightly different proteins of 265 kDa and 280 kDa. The C-terminal region contains a helicase/ATPase domain that shares sequence homology with the Sucrose Non-Fermenting 2 (SNF2) family of chromatin-remodeling enzymes (Gibbons et al., 1995) . The N-terminal region contains the ADD (ATRX-DNMT3-DNMT3L) domain with a plant homodomain zinc finger that may interact with the tail of histone H3 (Argentaro et al., 2007) . Mutations in ATRX that cause alpha thalassaemia/mental retardation syndrome X-linked or ATR-X syndrome correlate with high sequence conservation in these two domains, with 30% and 50% of the mutations occurring in the helicase/ATPase and ADD domains, respectively.
ATRX is known to interact with the death domain-associated protein DAXX (Xue et al., 2003) . More recently, researchers demonstrated that DAXX is a histone chaperone with specificity for the histone H3 variant, H3.3 (Drane et al., 2010; Goldberg et al., 2010; Lewis et al., 2010; Wong et al., 2010) . Although both ATRX and DAXX are required for H3.3 incorporation at telomeres, H3.3 incorporation in coding regions and near binding sites of transcription factors depends on a different histone chaperone, called Hira (Goldberg et al., 2010) . Thus, it is still unclear what factors determine where ATRX and DAXX incorporate H3.3.
The new findings by Law et al. make great strides toward answering this question. Previous immunofluorescence studies found that ATRX preferentially interacts with a number of repetitive DNA sequences, such as arrays of DNA encoding ribosomal RNA (i.e., rDNA arrays), a Y-specific satellite, and a repeat sequence adjacent to a telomere (PMID: 10742099). This led Law et al. to investigate whether ATRX binds to other repetitive elements across the genome. Many standard genome-wide protocols preclude such analysis because repetitive DNA elements give rise to spurious false positive signals, and thus these sequences are routinely removed from study. To overcome this technical hurdle, Law et al. adapt a chromatin immunoprecipitation sequencing approach (ChIPSeq) by normalizing the signal intensity to the size of the repeat. This provides a relatively unbiased view of ATRX binding across the genome and reveals 1000 stringent targets for ATRX.
A key finding of this study is that, in both human and mouse cells, the targets of ATRX include CpG islands (i.e., regions of the genome with a high frequency of unmethylated cytosine guanine dinucleotides) and G-rich tandem repeats. Both these DNA patterns are found at repeats in telomeres, sequences adjacent to telomeres (i.e., subtelomeric regions), and rDNA. Moreover, Law and colleagues show that ATRX predominantly binds to G-rich tandem repeats in or near genes that often display altered expression patterns in patients with ATR-X syndrome.
Law and colleagues found that, in erythroid cells, ATRX strongly localizes 1 kb upstream of the alpha globin gene HBM. This peak of ATRX binding occurs within a tandem repeat, called jz VNTR (CGCGGGGCGGGGG) n , where the number of repeats (n) varies between individuals. Interestingly, Law et al. find that when ATRX is mutated, the most downregulated genes in this gene cluster are the alpha-like globin genes closest to the jz VNTR repeat, and their downregulation scales with their proximity to the ATRX binding site. The identification of ATRX binding sequences within the alpha globin gene cluster provides a direct explanation as to why patients with mutations in ATRX exhibit alpha thalassaemia.
Then Law and colleagues go a step further and provide a molecular explanation for how two individuals with the same mutations in ATRX could have different severities of alpha thalassaemia. They demonstrate that patients with the largest expansion of the jz VNTR repeat have the greatest reduction in the expression of the alpha globin gene. At the extreme end of the spectrum, this ultimately leads to a total silencing or ''monoallelic expression'' of the alpha globin gene.
Some tandem repeat sequences that are rich in guanine nucleotides assemble into non-B-form structures called G-quadruplexes or G4 DNA (Figure 1 ). These structures form readily in vitro and, once created, are very stable. Law and colleagues note that 50% of the ATRX target sequences are predicted to likely adopt the G-quadruplex conformation, and they demonstrate that seven of these target sequences do indeed form G-quadruplex structures in isolation. Moreover, ATRX preferentially binds to the quadruplex structure over the B-form DNA in vitro. These observations suggest a model in which ATRX localizes to specific regions of the genome through its association to G-quadruplexes. Then through its interaction with DAXX, ATRX directs the incorporation of H3.3 into that region of the genome (Figure 1) . However, this model is only a hypothesis, and exactly what ATRX does at these target sites is still a key question. Several studies have shown that ATRX can alter nucleosome structure Xue et al., 2003) , but this does not rule out the possibility that the primary substrate of the ATRX helicase motor is nonchromatin DNA. For example, if ATRX removes DNA quadruplexes, the association with DAXX might be sufficient to promote chromatin assembly, which could then stabilize a B-DNA conformation (Figure 1) . Consistent with this hypothesis, a recent study found that lowering the levels of ATRX compromises telomere integrity (Wong et al., 2010) .
Another important question is, what is the function of H3.3 at these ATRX target sequences? Assembled onto DNA throughout the cell cycle, H3.3 is a nonreplicative histone that is often considered a hallmark of transcriptionally active chromatin in genetic regions. However, H3.3 is also known to mark many important regulatory DNA sequences, including both active gene promoters and DNA elements with insulator activity (Jin et al., 2009) . Interestingly, the presence of H3.3 at sites directed by ATRX is required for repression of transcription at telomeric repeats (Goldberg et al., 2010) . Furthermore, ATRX has additional links to repressive chromatin. For example, it associates with the heterochromatin proteins HP1a and HP1b (Berube et al., 2000) , and the presence of these proteins at telomeres is dependent on ATRX (Wong et al., 2010) .
Together these results suggest that perhaps ATRX and H3.3 maintain the boundary between regions of transcriptionally active chromatin and inactive chromatin (i.e., heterochromatin). Loss of ATRX may then result in the spreading of heterochromatin along DNA, resulting in the progressive silencing of nearby genes in cis, such as the alpha globin cluster. Such a scenario would also deplete the effective concentration of the protein factors necessary for the formation of heterochromatin, providing a plausible explanation for the defects in telomeric silencing seen in cells with ATRX and DAXX mutations. Clearly, the new findings by Law and colleagues demonstrate that repetitive DNA may be ''simple'' in terms of DNA sequence, but functionally they are anything but. Some DNA sequences rich in guanine and cytosine nucleotides are capable of adopting a G4-quadruplex configuration instead of the standard B-form duplex (left). The chromatin-remodeling protein ATRX binds preferentially to DNA sequences that have the potential to form G4-quadruplexes . ATRX belongs to a family of proteins that can translocate along duplex DNA, which may help to convert G4-quadruplexes to duplex DNA. ATRX also associates with a histone chaperone, DAXX, which can direct the assembly of nucleosomes containing the histone variant H3.3 (middle). Nucleosome assembly may then further stabilize DNA in a duplex configuration (right).
